Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Grimwade, D
   The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   D. Grimwade, "The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia", BEST P R C, 14(3), 2001, pp. 497-529
2. Kwong, YL; Au, WY; Chim, CS; Pang, A; Suen, C; Liang, R
   Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: Clinicopathological and molecular features of a pilot study
   AMERICAN JOURNAL OF HEMATOLOGY
   
   Y.L. Kwong et al., "Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: Clinicopathological and molecular features of a pilot study", AM J HEMAT, 66(4), 2001, pp. 274-279
3. Amin, HM; Saeed, S; Alkan, S
   Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17)
   BRITISH JOURNAL OF HAEMATOLOGY
   
   H.M. Amin et al., "Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17)", BR J HAEM, 115(2), 2001, pp. 287-297
4. Petti, MC; Pinazzi, MB; Diverio, D; Romano, A; Petrucci, MT; De Santis, S; Meloni, G; Tafuri, A; Mandelli, F; Lo Coco, F
   Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg (TM) CMA-676)
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M.C. Petti et al., "Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg (TM) CMA-676)", BR J HAEM, 115(1), 2001, pp. 63-65
5. Macheta, MP; Shun, JK; Yin, JAL
   Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M.P. Macheta et al., "Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis", BR J HAEM, 114(4), 2001, pp. 954-955
6. Gonzalez, M; Barragan, E; Bolufer, P; Chillon, C; Colomer, D; Borstein, R; Calasanz, MJ; Gomez-Casares, MT; Villegas, A; Marugan, I; Roman, J; Martin, G; Rayon, C; Deben, G; Tormo, M; Diaz-Mediavilla, J; Esteve, J; Gonzalez-San Miguel, J; Rivas, C; Perez-Equiza, K; Garcia-Sanz, R; Capote, FJ; Ribera, JM; Arias, J; Leon, A; Sanz, MA
   Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M. Gonzalez et al., "Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group", BR J HAEM, 114(1), 2001, pp. 99-103
7. Narita, M; Takahashi, M; Liu, AC; Ayres, F; Satoh, N; Abe, T; Nikkuni, K; Furukawa, T; Toba, K; Aizawa, Y
   Generation of dendritic cells from leukaemia cells of a patient with acutepromyelocytic leukaemia by culture with GM-CSF, IL-4 and TNF-alpha
   ACTA HAEMATOLOGICA
   
   M. Narita et al., "Generation of dendritic cells from leukaemia cells of a patient with acutepromyelocytic leukaemia by culture with GM-CSF, IL-4 and TNF-alpha", ACT HAEMAT, 106(3), 2001, pp. 89-94
8. Douer, D
   Transcription therapy for acute promyelocytic leukaemia
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   D. Douer, "Transcription therapy for acute promyelocytic leukaemia", EXPERT OP I, 9(2), 2000, pp. 329-346
9. Cupitt, JM
   A case for steroids in acute lung injury associated with the retinoic acidsyndrome
   ANAESTHESIA AND INTENSIVE CARE
   
   J.M. Cupitt, "A case for steroids in acute lung injury associated with the retinoic acidsyndrome", ANAESTH I C, 28(2), 2000, pp. 202-204
10. Charles, KS; Kanaa, M; Winfield, DW; Reilly, JT
    Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia
    CLINICAL AND LABORATORY HAEMATOLOGY
    
    K.S. Charles et al., "Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia", CLIN LAB H, 22(3), 2000, pp. 171-174
11. Kennedy, GA; Marlton, P; Cobcroft, R; Gill, D
    Molecular remission without blood product support using all-trans retinoicacid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    G.A. Kennedy et al., "Molecular remission without blood product support using all-trans retinoicacid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia", BR J HAEM, 111(4), 2000, pp. 1103-1105
12. de Botton, S; Chevret, S; Sanz, M; Dombret, H; Thomas, X; Guerci, A; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Geiser, K; Hess, U; Maloisel, F; Castaigne, S; Preudhomme, C; Chomienne, C; Degos, L; Fenaux, P
    Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S. de Botton et al., "Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial", BR J HAEM, 111(3), 2000, pp. 801-806
13. Brown, JE; Olujohungbe, A; Chang, J; Ryder, WDJ; Morganstern, GR; Chopra, R; Scarffe, JH
    All-trans retinoic acid (ATRA) and tranexamic acid: A potentially fatal combination in acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    J.E. Brown et al., "All-trans retinoic acid (ATRA) and tranexamic acid: A potentially fatal combination in acute promyelocytic leukaemia", BR J HAEM, 110(4), 2000, pp. 1010-1012
14. Amin, HM; Ergin, M; Denning, MF; Quevedo, ME; Alkan, S
    Characterization of apoptosis induced by protein kinase C inhibitors and its modulation by the caspase pathway in acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    H.M. Amin et al., "Characterization of apoptosis induced by protein kinase C inhibitors and its modulation by the caspase pathway in acute promyelocytic leukaemia", BR J HAEM, 110(3), 2000, pp. 552-562
15. Zompi, S; Legrand, O; Bouscary, D; Blanc, CM; Picard, F; Casadevall, N; Dreyfus, F; Marie, JP; Viguie, F
    Therapy-related acute myeloid leukaemia after successful therapy for acutepromyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S. Zompi et al., "Therapy-related acute myeloid leukaemia after successful therapy for acutepromyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature", BR J HAEM, 110(3), 2000, pp. 610-613
16. Sanz, MA; Martinez, JA; Barragan, E; Martin, G; Lo Coco, F
    All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M.A. Sanz et al., "All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia", BR J HAEM, 109(4), 2000, pp. 896-897
17. Di Bona, E; Avvisati, G; Castaman, G; Vegna, ML; De Sanctis, V; Rodeghiero, F; Mandelli, F
    Early haemorrhagic morbidity and mortality during remission induction withor without all-trans retinoic acid in acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    E. Di Bona et al., "Early haemorrhagic morbidity and mortality during remission induction withor without all-trans retinoic acid in acute promyelocytic leukaemia", BR J HAEM, 108(4), 2000, pp. 689-695
18. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
    Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid
    BRITISH JOURNAL OF HAEMATOLOGY
    
    K. Kitamura et al., "Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid", BR J HAEM, 108(4), 2000, pp. 696-702
19. Michieli, M; Damiani, D; Ermacora, A; Geromin, A; Michelutti, A; Masolini, P; Baccarani, M
    P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M. Michieli et al., "P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia", BR J HAEM, 108(4), 2000, pp. 703-709
20. Meijers, JCM; Oudijk, EJD; Mosnier, LO; Bos, R; Bouma, BN; Nieuwenhuis, HK; Fijnheer, R
    Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    J.C.M. Meijers et al., "Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia", BR J HAEM, 108(3), 2000, pp. 518-523
21. Takeshita, A; Shinjo, K; Naito, K; Ohnishi, K; Sugimoto, Y; Yamakawa, Y; Tanimoto, M; Kitamura, K; Naoe, T; Ouno, R
    Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA
    BRITISH JOURNAL OF HAEMATOLOGY
    
    A. Takeshita et al., "Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA", BR J HAEM, 108(1), 2000, pp. 90-92
22. O'Connor, SJM; Evans, PAS; Morgan, GJ
    Diagnostic approaches to acute promyelocytic leukaemia
    LEUKEMIA & LYMPHOMA
    
    S.J.M. O'Connor et al., "Diagnostic approaches to acute promyelocytic leukaemia", LEUK LYMPH, 33(1-2), 1999, pp. 53
23. Duprez, E; Saurin, AJ; Desterro, JM; Lallemand-Breitenbach, V; Howe, K; Boddy, MN; Solomon, E; de The, H; Hay, RT; Freemont, PS
    SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation
    JOURNAL OF CELL SCIENCE
    
    E. Duprez et al., "SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation", J CELL SCI, 112(3), 1999, pp. 381-393
24. Brown, DC; Tsuji, H; Larson, RS
    All-trans retinoic acid regulates adhesion mechanism and transmigration ofthe acute promyelocytic leukaemia cell line NB-4 under physiologic flow
    BRITISH JOURNAL OF HAEMATOLOGY
    
    D.C. Brown et al., "All-trans retinoic acid regulates adhesion mechanism and transmigration ofthe acute promyelocytic leukaemia cell line NB-4 under physiologic flow", BR J HAEM, 107(1), 1999, pp. 86-98
25. De Ridder, MC; Van der Plas, AJ; Erpelinck-Verschueren, CAJ; Lowenberg, B; Jansen, JH
    Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all-trans retinoic acid
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M.C. De Ridder et al., "Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all-trans retinoic acid", BR J HAEM, 106(1), 1999, pp. 107-110
26. Kinjo, K; Kizaki, M; Takayama, N; Michikawa, N; Oda, A; Okamoto, SI; Tahara, T; Kato, T; Miyazaki, H; Ikeda, Y
    Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment
    BRITISH JOURNAL OF HAEMATOLOGY
    
    K. Kinjo et al., "Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment", BR J HAEM, 105(2), 1999, pp. 382-387
27. Pulsoni, A; Stazi, A; Cotichini, R; Allione, B; Cerri, R; Di Bona, E; Nosari, AM; Pagano, L; Recchia, A; Ribersani, M; Rocchi, L; Veneri, D; Visani, G; Mandelli, F; Mele, A
    Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    A. Pulsoni et al., "Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia", EUR J HAEMA, 61(5), 1998, pp. 327-332
28. Sato, M; Matsushima, T; Takada, S; Hatsumi, N; Kim, K; Sakuraya, M; Saito, T; Tamura, J; Karasawa, M; Murakami, H; Naruse, T
    Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    M. Sato et al., "Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation", BONE MAR TR, 22(12), 1998, pp. 1219-1222
29. Huang, SY; Chang, CS; Tang, JL; Tien, HF; Kuo, TL; Huang, SF; Yao, YT; Chou, WC; Chung, CY; Wang, CH; Shen, MC; Chen, YC
    Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S.Y. Huang et al., "Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia", BR J HAEM, 103(4), 1998, pp. 1092-1095